Press release
Diabetic Neuropathy Market by Top International Players Lupin Pharmaceuticals, Lupin Global, Akorn, Inc, Abbott, Pfizer, Eli Lilly and Company, GlaxoSmithKline Pharma GmbH, Glenmark Pharmaceuticals, Assertio Therapeutics, Inc., Astellas Pharma US Forecast
Highlights of the Report:
In-depth analysis of various insights, namely, Diabetic Neuropathy Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Diabetic Neuropathy Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-neuropathy-market-100598
Key Players Operating in The Diabetic Neuropathy Market Include:
Lupin Pharmaceuticals
Lupin Global
Akorn, Inc
Abbott
Pfizer
Eli Lilly and Company
GlaxoSmithKline Pharma GmbH
Glenmark Pharmaceuticals
Assertio Therapeutics, Inc.
Astellas Pharma US
Development of New Treatment Options is Likely to Enable North America to Dominate
Geographically, the global diabetic neuropathy market is divided into Europe, North America, Latin America, the Middle East and Africa, and Asia Pacific. Amongst these regions, in 2018, North America held the largest share in the global diabetic neuropathy market. This is mainly because of the increasing investment in research and development initiatives for the development of new treatment options and an increasing number of diabetes cases. Asia Pacific is projected to trail the North America market, but exhibit a higher CAGR by the end of 2026. This is because of the rise in the awareness towards treatment and diagnosis of neuropathy, combined with an increasing number of cases of diabetes and other similar disorders.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/diabetic-neuropathy-market-100598
Prominent Companies Are Launching Products to Strengthen their Position in the Market
Endexx Corporation, a provider of phytonutrient-based nutritional products, announced the company’s investment in EcoHealth Neuropathy, Inc., a healthcare organization based in Arizona, in September 2018. The investment took place for launching clinical and technology propelled management of neuropathies like diabetic neuropathy. FDA approved LYRICA CR (pregabalin) extended-release tablets CV in October 2017, for the management of postherpetic neuralgia and for the once-daily therapy of neuropathic pain associated with diabetic peripheral neuropathy. Even before that, Daiichi Sankyo Company, Limited, a global pharmaceutical company, announced the Phase 3 administration of pain treatment of mirogabalin with the code of DS-5565 in February 2015. Its sole purpose was to manage diabetic peripheral neuropathic pain.
Detailed Table of Content:
Introduction
Executive Summary
Market Dynamics
Key Insights
Global Diabetic Neuropathy Market Analysis, Insights and Forecast, 2026
North America Diabetic Neuropathy industry, Analysis, Insights and Forecast, 2026
Europe Diabetic Neuropathy industry, Analysis, Insights and Forecast, 2026
Asia Pacific industry Diabetic Neuropathy Market Analysis, Insights and Forecast, 2026
Middle East and Africa Global Market Analysis, Insights and Forecast, 2026
Latin America Global Market Analysis, Insights and Forecast, 2026
Competitive Landscape
Company Profile
Conclusion
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/surgical-stapling-devices-market-101593
Report Focus:
Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Diabetic Neuropathy Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Neuropathy Market by Top International Players Lupin Pharmaceuticals, Lupin Global, Akorn, Inc, Abbott, Pfizer, Eli Lilly and Company, GlaxoSmithKline Pharma GmbH, Glenmark Pharmaceuticals, Assertio Therapeutics, Inc., Astellas Pharma US Forecast here
News-ID: 2542708 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Neuropathy
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Combatting Peripheral Neuropathy: Breakthroughs and Beyond
The Business Research Company recently released a comprehensive report on the Global Peripheral Neuropathy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the peripheral neuropathy market…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
